These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 39346900

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination of Prednisolone and Calcineurin Inhibitors Prevents Lung Function Decline in Patients with Anti-aminoacyl-tRNA Synthetase Antibody-Positive Polymyositis/Dermatomyositis.
    Yorishima Y, Tominaga M, Fujimoto K, Nagata S, Sumi A, Chikasue T, Okamoto M, Kaieda S, Matama G, Zaizen Y, Obara H, Kakuma T, Ida H, Kawayama T, Hoshino T.
    Kurume Med J; 2023 Nov 30; 69(1.2):19-30. PubMed ID: 37544752
    [Abstract] [Full Text] [Related]

  • 5. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
    Asakawa K, Yoshizawa K, Aoki A, Kimura Y, Tanaka T, Ohashi K, Hayashi M, Kikuchi T, Sato S, Takada T.
    Clin Rheumatol; 2020 Jul 30; 39(7):2171-2178. PubMed ID: 32056068
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
    Hozumi H, Fujisawa T, Nakashima R, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Inui N, Nakamura Y, Mimori T, Suda T.
    J Rheumatol; 2019 May 30; 46(5):509-517. PubMed ID: 30647164
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.
    J Rheumatol; 2019 Aug 30; 46(8):935-942. PubMed ID: 31092718
    [Abstract] [Full Text] [Related]

  • 9. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
    Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T.
    Autoimmunity; 2006 May 30; 39(3):233-41. PubMed ID: 16769657
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study.
    Nakazawa M, Kaneko Y, Takeuchi T.
    Clin Rheumatol; 2018 Mar 30; 37(3):765-771. PubMed ID: 28975463
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.
    Jiang M, Dong X, Zheng Y.
    Medicine (Baltimore); 2021 May 14; 100(19):e25816. PubMed ID: 34106621
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of obesity in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies.
    Yamaguchi K, Fukushima Y, Yamaguchi A, Itai M, Shin Y, Uno S, Muto S, Kouno S, Tsurumaki H, Yatomi M, Aoki-Saito H, Hara K, Koga Y, Sunaga N, Endo Y, Motegi SI, Nakasatomi M, Sakairi T, Ikeuchi H, Hiromura K, Hisada T, Tsushima Y, Kuwana M, Maeno T.
    Respir Med; 2022 Mar 14; 193():106741. PubMed ID: 35091206
    [Abstract] [Full Text] [Related]

  • 16. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q.
    BMC Pulm Med; 2021 Feb 12; 21(1):57. PubMed ID: 33579248
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease.
    Wakura R, Matsuda S, Kotani T, Shoda T, Takeuchi T.
    Sci Rep; 2020 Sep 24; 10(1):15692. PubMed ID: 32973255
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
    Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T.
    PLoS One; 2015 Sep 24; 10(3):e0120313. PubMed ID: 25789468
    [Abstract] [Full Text] [Related]

  • 20. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
    Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M.
    PLoS One; 2013 Sep 24; 8(4):e60442. PubMed ID: 23573256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.